Epidermal Barrier Parameters in Psoriasis: Implications in Assessing Disease Severity

Area of Science:

• Dermatology and immunology
• Skin barrier research
• Clinical trial analysis

Background:

• Psoriasis involves immune dysregulation and keratinocyte hyperproliferation, leading to skin barrier dysfunction.
• Altered skin integrity in psoriasis can cause xerosis, reduced elasticity, and friability.
• Understanding epidermal barrier changes is crucial for managing psoriasis effectively.

Purpose of the Study:

• To evaluate epidermal barrier dysfunction in chronic plaque psoriasis.
• To analyze dynamic changes in skin barrier parameters during topical treatments.
• To compare the efficacy of different topical therapies for psoriasis.

Main Methods:

• Observational study of adult chronic plaque psoriasis patients.
• Measurement of skin barrier parameters: stratum corneum hydration (SCH), transepidermal water loss (TEWL), elasticity, erythema, and melanin.
• Treatment arms included clobetasol propionate 0.5% and clobetasol propionate 0.5% with 10% urea.

Main Results:

• Lesional skin showed higher TEWL and erythema, with decreased SCH and elasticity compared to non-lesional skin.
• Severe psoriasis correlated with significantly higher TEWL, erythema, and lower SCH.
• SCH improved with clobetasol propionate 0.5% treatment; combination therapy with urea enhanced TEWL and SCH improvement.

Conclusions:

• Chronic plaque psoriasis is associated with significant epidermal barrier impairment.
• Topical clobetasol propionate improves SCH in psoriasis patients.
• Clobetasol propionate 0.5% combined with 10% urea offers superior benefits for TEWL and SCH compared to clobetasol propionate alone.